Qin, E. and Guilz, N. 2022. Using CRISPR-Cas9 In Human Fetuses to Prevent Trisomy 16 and Trisomy 22 Induced Miscarriages. Journal of Student Research. 11, 4 (Nov. 2022). DOI:https://doi.org/10.47611/jsrhs.v11i4.3859.